Do nutritional supplements have a role in age macular degeneration prevention?

Journal of Ophthalmology

Volumn 2014, Issue , 2014, Pages

  Pinazo Durán, Maria D ^a,b   Gómez Ulla, Francisco ^c,d,e   Arias, Luis ^f,g   Araiz, Javier ^h   Casaroli Marano, Ricardo ^f   Gallego Pinazo, Roberto ⁱ   García Medina, Jose J ^b,j   López Gálvez, Maria Isabel ^k,l   Manzanas, Lucía ^k,l   Salas, Anna ^m   Zapata, Miguel ⁿ   Diaz Llopis, Manuel ^a,i   García Layana, Alfredo ^o  

^a UNIVERSITY OF VALENCIA   (Spain)

^b Ophthalmic Research Unit Santiago Grisolia   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^d Ophthalmologic Institute Gomez Ulla   (Spain)

^e Foundation RetinaPlus   (Spain)

^f UNIVERSITY OF BARCELONA   (Spain)

^g HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^h UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

ⁱ HOSPITAL UNIVERSITARIO LA FE   (Spain)

^j UNIVERSITY OF MURCIA   (Spain)

^k UNIVERSITY OF VALLADOLID   (Spain)

^l HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^m HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

ⁿ UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^o UNIVERSITY CLINIC OF NAVARRA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893693047     PISSN: 2090004X     EISSN: 20900058     Source Type: Journal    
DOI: 10.1155/2014/901686     Document Type: Review

References (115)

1. Soubrane G., Cruess A., Lotery A., Pauleikhoff D., Monès J., Xu X., Zlateva G., Buggage R., Conlon J., Goss T. F., Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study. Archives of Ophthalmology 2007 125 9 1249 1254 2-s2.0-34548604340 10.1001/archopht.125.9.1249 (Pubitemid 47403034)
2. Miller J. W., Age-related macular degeneration revisited-piecing the puzzle: the LXIX Edward Jackson memorial lecture. The American Journal of Ophthalmology 2013 155 1 35
3. Lin T., Walker G. B., Kurji K., Fang E., Law G., Prasad S. S., Kojic L., Cao S., White V., Cui J. Z., Matsubara J. A., Parainflammation associated with advanced glycation endproduct stimulation of RPE in vitro: implications for age-related degenerative diseases of the eye. Cytokine 2013 62 369 381
4. Swaroop A., Chew E. Y., Rickman C. B., Abecasis G. R., Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annual Review of Genomics and Human Genetics 2009 10 19 43 2-s2.0-70350238360 10.1146/annurev.genom.9.081307. 164350
5. Aslam T., Delcourt C., Silva R., Holz F. G., Leys A., Garcia-Layana A., Souied E., Micronutrients in age-related macular degeneration. Ophthalmologica 2012 229 75 79
6. Age-Related Eye Disease Study Research Group, A randomized, placebo-controled clinical trial of high-dose supplementation with vitamins C and E, beta carotene and zinc for age-related macular degeneration and visual loss: AREDS report 8. Archives of Ophthalmology 2001 119 1417 1436
7. Age-Related Eye Disease Study 2 Research Group, Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. The Journal of the American Medical Association 2013 309 2005 2015
8. Fridovich I., The biology of oxygen radicals. The superoxide radical is an agent of oxygen toxicity: superoxide dismutases provide an important defense. Science 1978 201 4359 875 880 2-s2.0-0018263443
9. Halliwell B., Free radicals and antioxidants: updating a personal view. Nutrition Reviews 2012 70 5 257 265 2-s2.0-84860331697 10.1111/j.1753-4887.2012. 00476.x
10. Pryor W. A., Frei B., Free radicals and lipid peroxidation: what they are and how theygot that way. Natural Antioxidants in Human Health and Disease 1994 San Diego, Calif, USA Academic Press 1 24
11. Acar N., Gregoire S., Andre A., Juaneda P., Joffre C., Bron A. M., Creuzot-Garcher C. P., Bretillon L., Plasmalogens in the retina: in situ hybridization of dihydroxyacetone phosphate acyltransferase (DHAP-AT)-the first enzyme involved in their biosynthesis-and comparative study of retinal and retinal pigment epithelial lipid composition. Experimental Eye Research 2007 84 1 143 151 2-s2.0-33751210056 10.1016/j.exer.2006.09.009 (Pubitemid 44792060)
12. Acar N., Berdeaux O., Grégoire S., Cabaret S., Martine L., Gain P., Thuret G., Creuzot-Garcher C. P., Bron A. M., Bretillon L., Lipid composition of the human eye: are red blood cells a good mirror of retinal and optic nerve fatty acids? PLoS ONE 2012 7 4 2-s2.0-84859514274 10.1371/journal.pone.0035102 e35102
13. Holman R. T., Smythe L., Johnson S., Effect of sex and age on fatty acid composition of human serum lipids. The American Journal of Clinical Nutrition 1979 32 12 2390 2399 2-s2.0-0018634670 (Pubitemid 10177081)
14. Khan J. C., Shahid H., Thurlby D. A., Bradley M., Clayton D. G., Moore A. T., Bird A. C., Yates J., Age related macular degeneration and sun exposure, iris colour, and skin sensitivity to sunlight. The British Journal of Ophthalmology 2006 90 1 29 32 2-s2.0-29744453333 10.1136/bjo.2005.073825 (Pubitemid 43029891)
15. Smith W., Assink J., Klein R., Mitchell P., Klaver C. C. W., Klein B. E. K., Hofman A., Jensen S., Wang J. J., De Jong P. T. V. M., Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 2001 108 4 697 704 2-s2.0-0035078715 10.1016/S0161-6420(00)00580-7 (Pubitemid 32238465)
16. Klein R., Klein B. E., Jensen S. C., Mares-Perlman J. A., Cruickshanks K. J., Palta M., Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. Ophthalmology 1999 106 6 1056 1065 2-s2.0-0033497453 (Pubitemid 30191505)
17. Varma R., Fraser-Bell S., Tan S., Klein R., Azen S. P., Los Angeles Latino Eye Study Group, Prevalence of age-related macular degeneration in Latinos: the Los Angeles Latino eye study. Ophthalmology 2004 111 7 1288 1297 2-s2.0-3042518918 10.1016/j.ophtha.2004.01.023 (Pubitemid 38844823)
18. Zarbin M. A., Current concepts in the pathogenesis of age-related macular degeneration. Archives of Ophthalmology 2004 122 4 598 614 2-s2.0-1842478123 10.1001/archopht.122.4.598 (Pubitemid 38456297)
19. Krinsky N. I., Landrum J. T., Bone R. A., Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annual Review of Nutrition 2003 23 171 201 2-s2.0-0042866149 10.1146/annurev.nutr.23.011702.073307 (Pubitemid 37059721)
20. Pauleikhoff D., van Kuijk F. J., Bird A. C., Macular pigment and age-related macular degeneration. Ophthalmologe 2001 98 6 511 519 2-s2.0-0034945089 10.1007/s003470170110 (Pubitemid 32655543)
21. Wu J., Seregard S., Algvere P. V., Photochemical damage of the retina. Survey of Ophthalmology 2006 51 5 461 481 2-s2.0-33748049785 10.1016/j.survophthal.2006.06.009 (Pubitemid 44301311)
22. Algvere P. V., Marshall J., Seregard S., Age-related maculopathy and the impact of blue light hazard. Acta Ophthalmologica Scandinavica 2006 84 1 4 15 2-s2.0-33644763001 10.1111/j.1600-0420.2005.00627.x (Pubitemid 43337467)
23. Margrain T. H., Boulton M., Marshall J., Sliney D. H., Do blue light filters confer protection against age-related macular degeneration? Progress in Retinal and Eye Research 2004 23 5 523 531 2-s2.0-4043130958 10.1016/j.preteyeres.2004.05.001 (Pubitemid 39078360)
24. Klein R., Klein B. E., Jensen S. C., Cruickshanks K. J., Sunlight and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study. Archives of Ophthalmology 2001 119 246 250 (Pubitemid 32147933)
25. Biasutto L., Chiechi A., Couch R., Liotta L. A., Espina V., The RPE exosomes contain signaling phosphoproteins affected by oxidative stress. Experimental Cell Research 2013 119 2113 2123
26. Beatty S., Koh H., Phil M., Henson D., Boulton M., The role of oxidative stress in the pathogenesis of age-related macular degeneration. Survey of Ophthalmology 2000 45 2 115 134 2-s2.0-0033795036 10.1016/S0039-6257(00)00140-5
27. Calder P. C., Polyunsaturated fatty acids, inflammation, and immunity. Lipids 2001 36 9 1007 1024 2-s2.0-0035160023 (Pubitemid 33065203)
28. Mukherjee P. K., Marcheselli V. L., de Rivero Vaccari J. C., Gordon W. C., Jackson F. E., Bazan N. G., Photoreceptor outer segment phagocytosis attenuates oxidative stress-induced apoptosis with concomitant neuroprotectin D1 synthesis. Proceedings of the National Academy of Sciences of the United States of America 2007 104 32 13158 13163 2-s2.0-34548742176 10.1073/pnas.0705963104 (Pubitemid 351737609)
29. Pinazo-Durán M. D., Boscá-Gomar L., Anti-inflammatory properties of polyunsaturated fatty acid omega 3. Indications in Ophthalmology 2012 87 203 205
30. Blasiak J., Glowacki S., Kauppinen A., Kaarniranta K., Mitochondrial and nuclear DNA damage and repair in age-related macular degeneration. International Journal of Molecular 2013 14 2 2996 3010
31. Synowiec E., Sliwinski T., Danisz K., Blasiak J., Sklodowska A., Romaniuk D., Watala C., Szaflik J., Szaflik J. P., Association between polymorphism of the NQO1, NOS3 and NFE2L2 genes and AMD. Frontiers in Bioscience 2013 18 80 90
32. Kenney M. C., Hertzog D., Chak G., Atilano S. R., Khatibi N., Soe K., Nobe A., Yang E., Chwa M., Zhu F., Memarzadeh M., King J., Langberg J., Small K., Nesburn A. B., Boyer D. S., Udar N., Mitochondrial DNA haplogroups confer differences in risk for age-related macular degeneration: a case control study. BMC Medical Genetics 2013 14, article 4
33. Krohne T. U., Stratmann N. K., Kopitz J., Holz F. G., Effects of lipid peroxidation products on lipofuscinogenesis and autophagy in human retinal pigment epithelial cells. Experimental Eye Research 2010 90 3 465 471 2-s2.0-77649188326 10.1016/j.exer.2009.12.011
34. Pinazo-Durán M. D., Zanón-Moreno V., García-Medina J. J., Gallego-Pinazo R., Evaluation of presumptive biomarkers of oxidative stress, immune response and apoptosis in primary open-angle glaucoma. Current Opinion in Pharmacology 2013 13 98 107
35. Dǎnulescu R., Costin D., Use of blood markers in early diagnosis of oxidative stress in age related macular degeneration. Revista Medico-Chirurgicala a Societatii de Medici si Naturalisti din Iasi 2012 116 4 1136 1142
36. Yao J., Liu X., Yang Q., Zhuang M., Wang F., Chen X., Hang H., Zhang W., Liu Q., Proteomic analysis of the aqueous humor in patients with wet age-related macular degeneration. Proteomics Clinical Applications 2013 7 550 7 860
37. Libby R. T., Gould D. B., Endoplasmic reticulum stress as a primary pathogenic mechanism leading to age-related macular degeneration. Advances in Experimental Medicine and Biology 2010 664 403 409 2-s2.0-78149272587 10.1007/978-1-4419-1399-9-46
38. 2 in retinal iron-induced oxidative stress. Implications for age-related macular degeneration. Experimental Eye Research 2013 113 172 181
39. Nikoletopoulou V., Markaki M., Palikaras K., Tavernarakis N., Crosstalk between apoptosis, necrosis and autophagy. Biochimica et Biophysica Acta 2013 1833 12 3448 3459 10.1016/j.bbamcr.2013.06.001
40. D'Amours D., Sallmann F. R., Dixit V. M., Poirier G. G., Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis. Journal of Cell Science 2001 114 20 3771 3778 2-s2.0-0034760530 (Pubitemid 33041059)
41. Distler J. H., Strapatsas T., Huscher D., Dees C., Akhmetshina A., Kiener H. P., Tarner I. H., Maurer B., Walder M., Michel B., Gay S., Smolen J. S., Müller-Ladner U., Schett G., Distler O., Dysbalance of angiogenic and angiostatic mediators in patients with mixed connective tissue disease. Annals of the Rheumatic Diseases 2011 70 7 1197 1202 2-s2.0-79957631782 10.1136/ard.2010.140657
42. Kaiser P. K., Emerging therapies for neovascular age-related macular degeneration: drugs in the pipeline. Ophthalmology 2013 120 5, Supplement S11 S15
43. Rezzola S., Belleri M., Ribatti D., Costagliola C., Presta M., Semeraro F., A novel ex vivo murine retina angiogenesis (EMRA) assay. Experimental Eye Research 2013 112 51 56
44. Seki R., Yamagishi S., Matsui T., Yoshida T., Torimura T., Ueno T., Sata M., Okamura T., Pigment epithelium-derived factor (PEDF) inhibits survival and proliferation of VEGF-exposed multiple myeloma cells through its anti-oxidative properties. Biochemical and Biophysical Research Communications 2013 431 693 697
45. Stahl A., Stumpp M. T., Schlegel A., Ekawardhani S., Lehrling C., Martin G., Gulotti-Georgieva M., Villemagne D., Forrer P., Agostini H. T., Binz H. K., Highly potent VEGF-A-antagonistic DARPins as anti-angiogenic agents for topical and intravitreal applications. Angiogenesis 2013 16 101 111
46. Nakao S., Arima M., Ishikawa K., Kohno R., Kawahara S., Miyazaki M., Yoshida S., Enaida H., Hafezi-Moghadam A., Kono T., Ishibashi T., Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis. Investigative Ophthalmology & Visual Science 2012 53 4323 4328
47. Bhutto I. A., McLeod D. S., Hasegawa T., Kim S. Y., Merges C., Tong P., Lutty G. A., Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Experimental Eye Research 2006 82 1 99 110 2-s2.0-30344447284 10.1016/j.exer.2005.05.007 (Pubitemid 43063401)
48. Stefater J. A. III, Lewkowich I., Rao S., Mariggi G., Carpenter A. C., Burr A. R., Fan J., Ajima R., Molkentin J. D., Williams B. O., Wills-Karp M., Pollard J. W., Yamaguchi T., Ferrara N., Gerhardt H., Lang R. A., Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells. Nature 2011 474 7352 511 515 2-s2.0-79959553858 10.1038/nature10085
49. Klettner A., Kauppinen A., Blasiak J., Roider J., Salminen A., Kaarniranta K., Cellular and molecular mechanisms of age-related macular degeneration: from impaired autophagy to neovascularization. The International Journal of Biochemistry & Cell Biology 2013 45 1457 1467
50. Haddad W. M., Coscas G., Soubrane G., Age-related macular degeneration and apoptosis. Journal Francais d'Ophtalmologie 2003 26 3 307 311 2-s2.0-0038050582 (Pubitemid 36722932)
51. Dunaief J. L., Dentchev T., Ying G. S., Milam A. H., The role of apoptosis in age-related macular degeneration. Archives of Ophthalmology 2002 120 11 1435 1442 2-s2.0-0036875316 (Pubitemid 36406417)
52. Liadis N., Murakami K., Eweida M., Elford A. R., Sheu L., Gaisano H. Y., Hakem R., Ohashi P. S., Woo M., Caspase-3-dependent β -cell apoptosis in the initiation of autoimmune diabetes mellitus. Molecular and Cellular Biology 2005 25 9 3620 3629 2-s2.0-17644379373 10.1128/MCB.25.9.3620-3629.2005 (Pubitemid 40559568)
53. Matés J. M., Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 2000 153 1-3 83 104 2-s2.0-0034676493 10.1016/S0300-483X(00)00306-1
54. Sadaba L. M., Fernandez-Robredo P., Rodríguez J. A., García-Layana A., Antioxidant effects of vitamins C and E, multivitamin-mineral complex and flavonoids in a model of retinal oxidative stress: the ApoE-deficient mouse. Experimental Eye Research 2008 86 3 470 479 2-s2.0-40049108471 10.1016/j.exer.2007.11.020
55. Jialal I., Devaraj S., Kaul N., The effect of α -Tocopherol on monocyte proatherogenic activity. Journal of Nutrition 2001 131 389S 394S 2-s2.0-0035150318 (Pubitemid 32115387)
56. Zhang D., Al-Hendy M., Richard-Davis G., Montgomery-Rice V., Rajaratnam V., Al-Hendy A., Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells. Fertility and Sterility 2010 94 5 1887 1893 2-s2.0-77957205288 10.1016/j.fertnstert.2009.08.065
57. Ungvari Z., Orosz Z., Rivera A., Labinskyy N., Xiangmin Z., Csiszae A., Resveratrol increases vascular oxidative stress resistance. The FASEB Journal 2007 21 576.2
58. Medzhitov R., Janeway C. Jr., Innate immunity. The New England Journal of Medicine 2000 343 5 338 344 2-s2.0-0034601309 10.1056/NEJM200008033430506 (Pubitemid 30616701)
59. Cao S., Walker G. B., Wang X., Cui J. Z., Matsubara J. A., Altered cytokine profiles of human retinal pigment epithelium: oxidant injury and replicative senescence. Molecular Vision 2013 19 718 728
60. Parmeggiani F., Gemmati D., Costagliola C., Sebastiani A., Incorvaia C., Predictive role of C677T MTHFR polymorphism in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration. Pharmacogenomics 2009 10 1 81 95 2-s2.0-62649151512 10.2217/14622416.10.1.81
61. Cruz-Guilloty F., Saeed A. M., Echegaray J. J., Duffort S., Ballmick A., Tan Y., Betancourt M., Viteri E., Ramkhellawan G. C., Ewald E., Feuer W., Huang D., Wen R., Hong L., Wang H., Laird J. M., Sene A., Apte R. S., Salomon R. G., Hollyfield J. G., Perez V. L., Infiltration of proinflammatory m1 macrophages into the outer retina precedes damage in a mouse model of age-related macular degeneration. International Journal of Inflammation 2013 2013 12 503725 10.1155/2013/503725
62. Casaroli-Marano R. P., Peinado-Onsurbe J., Reina M., Staels B., Auwerx J., Vilaró S., Lipoprotein lipase in highly vascularized structures of the eye. Journal of Lipid Research 1996 37 5 1037 1044 2-s2.0-0029894785 (Pubitemid 26182336)
63. Anderson D. H., Talaga K. C., Rivest A. J., Barron E., Hageman G. S., Johnson L. V., Characterization of β amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Experimental Eye Research 2004 78 2 243 256 2-s2.0-0345760069 10.1016/j.exer.2003.10.011 (Pubitemid 38077231)
64. Hageman G. S., Luthert P. J., Chong N. H. V., Johnson L. V., Anderson D. H., Mullins R. F., An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Progress in Retinal and Eye Research 2001 20 6 705 732 2-s2.0-0034832029 10.1016/S1350-9462(01)00010-6 (Pubitemid 32918285)
65. Alexander J. J., Bao L., Jacob A., Kraus D. M., Holers V. M., Quigg R. J., Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis. Biochimica et Biophysica Acta 2003 1639 3 169 176 2-s2.0-0242577358 10.1016/j.bbadis.2003.09. 005 (Pubitemid 37421424)
66. Newsome D. A., Swartz M., Leone N. C., Elston R. C., Miller E., Oral zinc in macular degeneration. Archives of Ophthalmology 1988 106 2 192 198 2-s2.0-0023851021 (Pubitemid 18056413)
67. Richer S., Stiles W., Statkute L., Pulido J., Frankowski J., Rudy D., Pei K., Tsipursky M., Nyland J., Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 2004 75 4 216 230 2-s2.0-2542432254 (Pubitemid 39208022)
68. Stur M., Tittl M., Reitner A., Meisinger V., Oral zinc and the second eye in age-related macular degeneration. Investigative Ophthalmology and Visual Science 1996 37 7 1225 1235 2-s2.0-0029931478 (Pubitemid 26177299)
69. Newsome D. A., A randomized, prospective, placebo-controlled clinical trial of a novel zinc-monocysteine compound in age-related macular degeneration. Current Eye Research 2008 33 7 591 598 2-s2.0-46749115130 10.1080/ 02713680802178437 (Pubitemid 351948491)
70. Richer S., Multicenter ophthalmic and nutritional age-related macular degeneration study-part 2: antioxidant intervention and conclusions. Journal of the American Optometric Association 1996 67 1 30 49 2-s2.0-0029680973
71. Feher J., Kovacs B., Kovacs I., Schvoller M., Papale A., Gabrieli C. B., Improvement of visual functions and fundus alterations in early age-related macular degeneration treated with a combination of acetyl-L-carnitine, n-3 fatty acids, and coenzyme Q10. Ophthalmologica 2005 219 3 154 166 2-s2.0-20544448450 10.1159/000085248 (Pubitemid 40868784)
72. Chong E. W., Kreis A. J., Wong T. Y., Simpson J. A., Guymer R. H., Dietary ω -3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Archives of Ophthalmology 2008 126 6 826 833 2-s2.0-45149132510 10.1001/archopht.126.6.826 (Pubitemid 351831334)
73. Christen W. G., Schaumberg D. A., Glynn R. J., Buring J. E., Dietary ω -3 fatty acid and fish intake and incident age-related macular degeneration in women. Archives of Ophthalmology 2011 129 7 921 929 2-s2.0-79960178230 10.1001/archophthalmol.2011.34
74. van Leeuwen R., Boekhoorn S., Vingerling J. R., Witteman J. C. M., Klaver C. C. W., Hofman A., De Jong P. T. V. M., Dietary intake of antioxidants and risk of age-related macular degeneration. The Journal of the American Medical Association 2005 294 24 3101 3107 2-s2.0-29544441148 10.1001/jama.294.24.3101 (Pubitemid 43016801)
75. Flood V., Smith W., Wang J. J., Manzi F., Webb K., Mitchell P., Dietary antioxidant intake and incidence of early age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology 2002 109 12 2272 2278 2-s2.0-0036897333 10.1016/S0161-6420(02)01263-0 (Pubitemid 35417110)
76. Chow E., Seddon J. M., Rosner B., Willett W. C., Hankinson S. E., Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Archives of Ophthalmology 2004 122 6 883 892 2-s2.0-2942617206 10.1001/archopht.122.6.883 (Pubitemid 38736248)
77. van den Langenberg G. M., Mares-Perlman J. A., Klein R., Klein B. E. K., Brady W. E., Palta M., Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the beaver dam eye study. The American Journal of Epidemiology 1998 148 2 204 214 2-s2.0-0032527738 (Pubitemid 28334898)
78. Moeller M. S., Parekh N., Tinker L. L., Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-Related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative. Archives of Ophthalmology 2006 124 8 1151 1162 2-s2.0-33747185607 10.1001/archopht.124.8.1151 (Pubitemid 44232345)
79. Taylor H., Tikellis G., Robman L., Vitamin E supplementation and macular degeneration: randomised controlled trial. British Medical Journal 2002 325 7354 11 14 2-s2.0-0037031048 (Pubitemid 34747932)
80. Hodge W. G., Schachter H. M., Barnes D., Pan Y., Lowcock E. C., Zhang L., Sampson M., Morrison A., Tran K., Miguelez M., Lewin G., Efficacy of ω -3 fatty acids in preventing age-related macular degeneration: a systematic review. Ophthalmology 2006 113 7 1165 1173 2-s2.0-33745358664 10.1016/j.ophtha.2006.02.043 (Pubitemid 43947239)
81. Chong E. W., Wong T. Y., Kreis A. J., Simpson J. A., Guymer R. H., Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis. The British Medical Journal 2007 335 7623 755 759 2-s2.0-35348966298 10.1136/bmj.39350.500428.47 (Pubitemid 47612631)
82. Soused E. H., Delcourt C., Querques G., Bassols A., Merle B., Zourdani A., Smith T., Benlian P., Nutritional AMD treatment 2 study group. Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the nutritional AMD treatment 2 study. Ophthalmology 2013 120 8 1619 1631
83. Teikari J. M., Laatikainen L., Virtamo J., Haukka J., Rautalahti M., Liesto K., Albanes D., Taylor P., Heinonen O. P., Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy. Acta Ophthalmologica Scandinavica 1998 76 2 224 229 2-s2.0-0031966020 (Pubitemid 28177215)
84. Heinonen O. P., Huttunen J. K., Albanes D., Haapakoski J., Palmgren J., Pietinen P., Pikkarainen J., Virramo J., Edwards B. K., Greenwald P., Hartman A., Taylor P. R., Haakka J., Jarvinen P., Malila N., Rapola S., Jokinen P., Karjalainen A., Lauronen J., The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Annals of Epidemiology 1994 4 1 1 10 2-s2.0-0028120012 (Pubitemid 24102333)
85. Goodman G. E., Omenn G. S., Thornquist M. D., Lund B., Metch B., Gylys-Colwell I., The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokers. Cancer Epidemiology Biomarkers and Prevention 1993 2 4 389 396 2-s2.0-0027635263
86. Omenn G. S., Goodman G. E., Thornquist M. D., Balmes J., Cullen M. R., Glass A., Keogh J. P., Meyskens Jr.F. L., Valanis B., Williams Jr.J. H.Barnhart S., Hammar S., Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. The New England Journal of Medicine 1996 334 18 1150 1155 2-s2.0-9244262406 10.1056/NEJM199605023341802 (Pubitemid 26137973)
87. Tan J. S., Wang J. J., Flood V., Rochtchina E., Smith W., Mitchell P., Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 2008 115 2 334 341 2-s2.0-38749097003 10.1016/j.ophtha.2007.03.083 (Pubitemid 351175680)
88. Olson J. H., Erie J. C., Bakri S. J., Nutritional supplementation and age-related macular degeneration. Seminars in Ophthalmology 2011 26 3 131 136 2-s2.0-79957585321 10.3109/08820538.2011.577131
89. Food and Nutrition Board, Institute of Medicine, Copper. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc 2001 Washington, DC, USA National Academy Press 224 257
90. Kang Z. B., Ge Y., Chen Z., Cluette-Brown J., Laposata M., Leaf A., Kang: J. X., Adenoviral gene transfer of Caenorhabditis elegans n-3 fatty acid desaturase optimizes fatty acid composition in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America 2001 98 7 4050 4054 (Pubitemid 32249896)
91. Pennesi M. E., Neuringer M., Courtney R. J., Animal models of age related macular degeneration. Molecular Aspects of Medicine 2012 33 487 509
92. Koto T., Nagai N., Mochimaru H., Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice. Investigative Ophthalmology & Visual Science 2007 48 9 4328 4334 (Pubitemid 351261066)
93. Tuo J., Bojanowski C. M., Zhou M., Shen D., Ross R. J., Rosenberg K. L., Cameron D. J., Yin C., Kowalak J. A., Zhuang Z., Zhang K., Chan C. C., Murine Ccl2/Cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. Investigative Ophthalmology and Visual Science 2007 48 8 3827 3836 2-s2.0-34648846532 10.1167/iovs.07-0051 (Pubitemid 351261124)
94. Chan C. C., Ross R. J., Shen D., Ding X., Majumdar Z., Bojanowski C. M., Zhou M., Salem Jr.N.Bonner R., Tuo J., Ccl2/Cx3cr1-deficient mice: an animal model for age-related macular degeneration. Ophthalmic Research 2008 40 3-4 124 128 2-s2.0-42449086469 10.1159/000119862 (Pubitemid 351562889)
95. Tuo J., Ross R. J., Herzlich A. A., Shen D., Ding X., Zhou M., Coon S. L., Hussein N., Salem Jr.N. Chan C. C., A high omega-3 fatty acid diet reduces retinal lesions in a murine model of macular degeneration. The American Journal of Pathology 2009 175 2 799 807 2-s2.0-68449094580 10.2353/ajpath.2009.090089
96. Bellhorn R. W., King C. D., Aguirre G. D., Ripps H., Siegel I. M., Tsai H. C., Pigmentary abnormalities of the macula in rhesus monkeys: clinical observations. Investigative Ophthalmology and Visual Science 1981 21 6 771 781 2-s2.0-0019777353 (Pubitemid 12250372)
97. Stafford T. J., Anness S. H., Fine B. S., Spontaneous degenerative maculopathy in the monkey. Ophthalmology 1984 91 5 513 521 2-s2.0-0021361247 (Pubitemid 14149082)
98. Nicolas M. G., Fujiki K., Murayama K., Suzuki M. T., Mineki R., Hayakawa M., Yoshikawa Y., Cho F., Kanai A., Studies on the mechanism of early onset macular degeneration in cynomolgus (Macaca fascicularis) monkeys. I. Abnormal concentrations of two proteins in the retina. Experimental Eye Research 1996 62 3 211 219 2-s2.0-0029922872 10.1006/exer.1996.0026 (Pubitemid 26127997)
99. Umeda S., Suzuki M. T., Okamoto H., Ono F., Mizota A., Terao K., Yoshikawa Y., Tanaka Y., Iwata T., Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis). The FASEB Journal 2005 19 12 1683 1685 2-s2.0-26444583909 10.1096/fj.05-3525fje (Pubitemid 41429529)
100. Neuringer M., Francis P. J., Renner L., Weiss A., Jeffrey B. G., Atrophic macular degeneration in rhesus monkeys deficient in xanthophylls and n-3 fatty acids. ARVO Abstract 2010 Association for Research in Vision and Ophthalmology
101. Gouras P., Ivert L., Neuringer M., Mattison J. A., Topographic and age-related changes of the retinal epithelium and Bruch's membrane of rhesus monkeys. Graefe's Archive for Clinical and Experimental Ophthalmology 2010 248 7 973 984 2-s2.0-77955663985 10.1007/s00417-010-1325-x
102. Renner L., Hurst S., McGill T., Weiss A., Stout T., Wilson D., Neuringer M., Progression of atrophic macular degeneration in rhesus monkeys deficient in lutein/zeaxanthin and omega-3 fatty acids. ARVO Abstract 2013 Association for Research in Vision and Ophthalmology
103. Barker F. M. II, Snodderly D. M., Johnson E. J., Schalch W., Koepcke W., Gerss J., Neuringer M., Nutritional manipulation of primate retinas. V: effects of lutein, zeaxanthin, and n-3 fatty acids on retinal sensitivity to blue-light-induced damage. Investigative Ophthalmology & Visual Science 2011 52 3934 3942
104. Tsuzuki T., Shibata A., Kawakami Y., Nakagawa K., Miyazawa T., Conjugated eicosapentaenoic acid inhibits vascular endothelial growth factor-induced angiogenesis by suppressing the migration of human umbilical vein endothelial cells. Journal of Nutrition 2007 137 3 641 646 2-s2.0-33947175572 (Pubitemid 46397496)
105. Papadopoulos N., Martin J., Ruan Q., Rafique A., Rosconi M. P., Shi E., Pyles E. A., Yancopoulos G. D., Stahl N., Wiegand S. J., Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab. Angiogenesis 2012 15 171 185 2-s2.0-84856390976 10.1007/s10456-011-9249-6
106. Richard D., Kefi K., Barbe U., Bausero P., Visioli F., Polyunsaturated fatty acids as antioxidants. Journal of Regenerative Medicine and Tissue Engineering 2008 2 383 393
107. Banumathi E., Haribalaganesh R., Babu S. S. P., Kumar N. S., Sangiliyandi G., High-yielding enzymatic method for isolation and culture of microvascular endothelial cells from bovine retinal blood vessels. Microvascular Research 2009 77 3 377 381 2-s2.0-64049097456 10.1016/j.mvr.2008.12.005
108. Sheikpranbabu S., Haribalaganesh R., Banumathi E., Sirishkumar N., Lee K. J., Gurunathan S., Pigment epithelium-derived factor inhibits advanced glycation end-product-induced angiogenesis and stimulates apoptosis in retinal endothelial cells. Life Sciences 2009 85 719 731
109. Morita I., Zhang Y. W., Murota S. I., Eicosapentaenoic acid protects endothelial cell function injured by hypoxia/reoxygenation. Annals of the New York Academy of Sciences 2001 947 394 397 2-s2.0-0035680544 (Pubitemid 34059944)
110. Mukherjee P. K., Marcheselli V. L., Serhan C. N., Bazan N. G., Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proceedings of the National Academy of Sciences of the United States of America 2004 101 22 8491 8496 2-s2.0-2942625603 10.1073/pnas.0402531101 (Pubitemid 38736602)
111. Chucair A. J., Rotstein N. P., Sangiovanni J. P., During A., Chew E. Y., Politi L. E., Lutein and zeaxanthin protect photoreceptors from apoptosis induced by oxidative stress: relation with docosahexaenoic acid. Investigative Ophthalmology and Visual Science 2007 48 11 5168 5177 2-s2.0-38449115096 10.1167/iovs.07-0037 (Pubitemid 351260928)
112. Kannan R., Zhang N., Sreekumar P. G., Spee C. K., Rodriguez A., Barron E., Hinton D. R., Stimulation of apical and basolateral vascular endothelial growth factor-A and vascular endothelial growth factor-C secretion by oxidative stress in polarized retinal pigment epithelial cells. Molecular Vision 2006 12 1649 1659 2-s2.0-33845983659 (Pubitemid 46050311)
113. Kagan D. B., Liu H., Hutnik C. M., Efficacy of various antioxidants in the protection of the retinal pigment epithelium from oxidative stress. Clinical Ophthalmology 2012 6 1471 1476 10.2147/OPTH.S35139
114. Evans J., Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis. Eye 2008 22 6 751 760 2-s2.0-45449118333 10.1038/eye.2008.100 (Pubitemid 351850510)
115. Sujak A., Gabrielska J., Grudziński W., Borc R., Mazurek P., Gruszecki W. I., Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: the structural aspects. Archives of Biochemistry and Biophysics 1999 371 2 301 307 2-s2.0-0033571659 10.1006/abbi.1999.1437